Safety study of RAZI- MMR vaccine in 18-49 years old volunteers

Phase 1

• Conditions: Condition 1: Measles. Condition 2: Mumps. Condition 3: Rubella.; Measles; Mumps; Rubella

• Registration Number: IRCT138904284412N1
• Lead Sponsor: Razi Vaccine and Serum Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Inclusion Criteria:
Negative history of any contact with patients infected by Measles, Rubella or Mumps viruses during the last two months; Not being under Immunocompromising treatment; Giving Informed Consent; Not being Pregnant and no plan for pregnancy within the next three months; Negative history of Autoimmune disorders; Not being under Radiotherapy; Negative history of any Chronic diseases.

Exclusion Criteria

Positive history of Immunodeficiency; Positive history of Congenital disorders; Positive history of Genetic disease;Positive history of Liver disease; Positive history of Kidney disease;Temperature > 38.0 °C at the time of the first visit; Presence of an Acute Febrile disease at the time of the fist visit; Positive history of blood transfusion during the last three months; Positive history of receiving intramascular immunogluboline during the last three months; Positive history of Hypersensitivity to Vaccine; Positive history of severe adverse effect after previous MMR Vaccine injection; Positive history of active tuberculosis; Positive history of egg hypersensitivity; Positive history of thrombocytopenia.

Study & Design

• Study Type: interventional
• Study Design: Not specified